Company profile: Biochrom
1.1 - Company Overview
Company description
- Provider of scientific instruments for clinical, life science, and industrial applications, including UV/Vis and compact spectrophotometers, microvolume spectrophotometers, colorimeters, amino acid analyzers and related chemicals, as well as microplate readers and washers, plus service contracts and preventive maintenance.
Products and services
- BioDrop Duo+ Microvolume Spectrophotometer: Microvolume instrument with a sample port for small volumes and a cuvette port for standard use, featuring pre-programmed DNA, RNA, and protein assay methods
- Biowave 3+ CT Spectrophotometer: Pre-programmed spectrophotometer for nucleic acid and protein quantification, offering flexible data viewing and export options
- Ultrospec 7500 UV-Vis Spectrophotometer: IQ/OQ/PQ-compliant instrument with a touchscreen display, customizable with various accessories for various UV/Vis applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biochrom
Gateway Genomics
HQ: France
Website
- Description: Provider of genetically based tests for families and cancer care, including SneakPeek Early Gender Test to determine fetal sex from a small maternal blood sample as early as six weeks; Foresight Carrier Screen for inherited conditions; Prequel Prenatal Screen to identify risk of chromosomal conditions like Down syndrome from week 10; and oncology tests Prolaris and Precise to assess prostate cancer aggressiveness and tumor variants to guide treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gateway Genomics company profile →
Axenis
HQ: France
Website
- Description: Provider of humanized mouse models as preclinical tools in immunology for the pharmaceutical industry, biotechnology companies, and academic research, using new immunocompromised mouse strains permissive to human tissue xenograft transplantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axenis company profile →
Purigen Biosystems
HQ: United States
Website
- Description: Provider of automated solutions for DNA and RNA purification using a proprietary approach with isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface; technology is agnostic to nucleic acid size or sequence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Purigen Biosystems company profile →
IMGM Laboratories
HQ: Germany
Website
- Description: Provider of advanced genomic services via a service center in Martinsried, Germany for academic and industrial genome research, serving pharma, diagnostics, academia and biotech. Accredited to DIN EN ISO/IEC 17025 for gene expression analysis using Agilent microarrays and qPCR, and offering first-class NGS, metagenomic sequencing, biomarker discovery, pharmacogenetics, and qPCR/ddPCR-based biodistribution studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMGM Laboratories company profile →
SeQure Dx
HQ: United States
Website
- Description: Provider of safety data and diagnostic platforms for on- and off-target CRISPR gene editing therapies. Offers NoteSeQ (ONE-seq) for profiling off-target sites, ScopeSeQ for validating candidate edits via next-generation sequencing, risk assessment across the development lifecycle, discovery/IND support, clinical trial patient risk management, and post-approval diagnostic management with patient and physician education.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeQure Dx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biochrom
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biochrom
2.2 - Growth funds investing in similar companies to Biochrom
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biochrom
4.2 - Public trading comparable groups for Biochrom
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →